Earlier this month the FDA approved Keytruda, manufactured by Merck, to treat melanoma. Keytruda disrupts the cancer cells that tell the body's immune system not to attack the cancer cells as intruders. Keytruda, and other drugs in this class are already being tested...
The 11th Annual International Symposium on Malignant Mesothelioma, hosted by the Mesothelioma Applied Research Foundation (Meso Foundation), scheduled for March 5-7, 2014 in Alexandria, Virginia is available for patients and families and the entire mesothelioma...
Nanotechnology is a new field that offers scientists the ability to control matter in very small dimensions including enhancement of the delivery of drugs to treat mesothelioma and lung cancer. Materials at the nanoscale can have different properties compared to their...
Ken Adler, a professor of cell biology at North Carolina State University developed a compound similar to a protein called a peptide. The peptide was developed to stop inflammation from spreading in patients suffering from lung problems such as chronic bronchitis or...
Subscribe To This Blog’s Feed